UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sequencing of KRAS and NRAS in 1501 colorectal carcinomas reveals significant share of mutations, which are not included in common diagnostic kits

Annals of oncology, 2018-10, Vol.29, p.viii195-viii195

2018

Volltextzugriff (PDF)

Lung cancers carrying distinct ALK fusion variants demonstrate similar responsiveness to ALK tyrosine kinase inhibitors

Annals of oncology, 2018-10, Vol.29, p.viii502-viii502

2018

Volltextzugriff (PDF)

EGFR T790M mutation in treatment-naïve tumor samples: Low frequency, evidence for interaction with EGFR TKI-sensitizing mutations and lack of clear predictive value

Annals of oncology, 2018-09, Vol.29, p.vi4-vi4

2018

Volltextzugriff (PDF)

Spectrum of APC and MUTYH germ‐line mutations in Russian patients with colorectal malignancies

Clinical genetics, 2018-05, Vol.93 (5), p.1015-1021

2018

Volltextzugriff (PDF)

PCR-based detection of EGFR, ALK, KRAS and BRAF mutations in Russian patients with lung adenocarcinoma: a single-center experience

Neoplasma, 2018-01, Vol.65 (6), p.972-979

2018

Volltextzugriff (PDF)

The role of molecular diagnostics in the choice of therapy for biliary tract cancers

Sibirskiĭ onkologicheskiĭ zhurnal, 2024-03, Vol.23 (1), p.130-141

2024

Volltextzugriff (PDF)

1051 POSTER High Level of MiR-21, MiR-10b and MiR-31 Expression in Bilateral Versus Unilateral Breast Carcinomas

European journal of cancer (1990), 2011, Vol.47, p.S111-S111

2011

Volltextzugriff (PDF)

CLINICAL EFFICACY OF TARGETED THERAPY TOWARDS METASTATIC LUNG CANCER CARRYING DISTINCT TYPES OF ALK REARRANGEMENTS

Sibirskiĭ onkologicheskiĭ zhurnal, 2020-09, Vol.19 (4), p.132-137

2020

Volltextzugriff (PDF)

1203P The analysis of ALK fusion variants in 4991 EGFR/MET mutation-negative non-squamous non-small cell lung carcinomas (NSCLCs)

Annals of oncology, 2021-09, Vol.32, p.S960-S960

2021

Volltextzugriff (PDF)

2004P Exome sequencing of germ-line DNA from young-onset and/or ALK-fusion-positive lung cancer patients

Annals of oncology, 2020-09, Vol.31, p.S1118-S1118

2020

Volltextzugriff (PDF)

P57.02 High Frequency of Heterozygous Truncating Germ-Line Mutations in DNA Repair Genes in Young-Onset and/or ALK-Rearranged Lung Cancer Patients

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S534-S534

2021

Volltextzugriff (PDF)

Preferential expression of the affected MET allele in lung carcinomas with heterozygous MET exon 14 skipping mutations: Implications for clinical testing

Annals of oncology, 2019-10, Vol.30, p.v638-v639

2019

Volltextzugriff (PDF)

1550PPreferential expression of the affected MET allele in lung carcinomas with heterozygous MET exon 14 skipping mutations: Implications for clinical testing

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

1550P - Preferential expression of the affected MET allele in lung carcinomas with heterozygous MET exon 14 skipping mutations: Implications for clinical testing

Annals of oncology, 2019-10, Vol.30, p.v638-v639

2019

Volltextzugriff (PDF)

P37.21 Improvement of PCR-Based Detection of ALK Rearrangements

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S450-S451

2021

Volltextzugriff (PDF)

10PEGFR T790M mutation in treatment-naïve tumor samples: Low frequency, evidence for interaction with EGFR TKI-sensitizing mutations and lack of clear predictive value

Annals of oncology, 2018-09, Vol.29 (suppl_6)

2018

Volltextzugriff (PDF)

586PSequencing of KRAS and NRAS in 1501 colorectal carcinomas reveals significant share of mutations, which are not included in common diagnostic kits

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

1395PLung cancers carrying distinct ALK fusion variants demonstrate similar responsiveness to ALK tyrosine kinase inhibitors

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Role of CYP2D6 gene polymorphism in individual's ability to quit smoking

European journal of cancer supplements, 2008, Vol.6 (9), p.206-206

2008

Volltextzugriff (PDF)

Hereditary Breast-Ovarian Cancer Syndrome in Russia

Actanaturae, 2010-10, Vol.2 (4), p.31-35

2010

Volltextzugriff (PDF)

High frequency of BRCA1 5382insC mutation in Russian breast cancer patients

European journal of cancer (1990), 2006-07, Vol.42 (10), p.1380-1384

2006

Volltextzugriff (PDF)

Coding polymorphisms in Casp5, Casp8 and DR4 genes may play a role in predisposition to lung cancer

Cancer letters, 2009-06, Vol.278 (2), p.183-191

2009

Volltextzugriff (PDF)

First-line treatment of EGFR mutation-positive non-small cell lung cancer (NSCLC) by gefitinib

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e19088-e19088

2009

Volltextzugriff (PDF)

First Russian nationwide molecular epidemiological study for melanoma: results of BRAF mutation analysis

Arkhiv patologii, 2014-05, Vol.76 (3), p.65

2014

Volltextzugriff (PDF)

Pharmacoeconomic analysis of gefitinib therapy in patients with non-cell cell lung cancer

Voprosy onkologij, 2012, Vol.58 (3), p.352

2012

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(75)

Publikationsform

Artikel
(81)
Berichte
(1)

Sprache

Englisch
(73)
Russisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sequencing of KRAS and NRAS in 1501 colorectal carcinomas reveals significant share of mutations, which are not included in common diagnostic kits

Lung cancers carrying distinct ALK fusion variants demonstrate similar responsiveness to ALK tyrosine kinase inhibitors

EGFR T790M mutation in treatment-naïve tumor samples: Low frequency, evidence for interaction with EGFR TKI-sensitizing mutations and lack of clear predictive value

Spectrum of APC and MUTYH germ‐line mutations in Russian patients with colorectal malignancies

PCR-based detection of EGFR, ALK, KRAS and BRAF mutations in Russian patients with lung adenocarcinoma: a single-center experience

The role of molecular diagnostics in the choice of therapy for biliary tract cancers

1051 POSTER High Level of MiR-21, MiR-10b and MiR-31 Expression in Bilateral Versus Unilateral Breast Carcinomas

CLINICAL EFFICACY OF TARGETED THERAPY TOWARDS METASTATIC LUNG CANCER CARRYING DISTINCT TYPES OF ALK REARRANGEMENTS

1203P The analysis of ALK fusion variants in 4991 EGFR/MET mutation-negative non-squamous non-small cell lung carcinomas (NSCLCs)

2004P Exome sequencing of germ-line DNA from young-onset and/or ALK-fusion-positive lung cancer patients

P57.02 High Frequency of Heterozygous Truncating Germ-Line Mutations in DNA Repair Genes in Young-Onset and/or ALK-Rearranged Lung Cancer Patients

Preferential expression of the affected MET allele in lung carcinomas with heterozygous MET exon 14 skipping mutations: Implications for clinical testing

1550PPreferential expression of the affected MET allele in lung carcinomas with heterozygous MET exon 14 skipping mutations: Implications for clinical testing

1550P - Preferential expression of the affected MET allele in lung carcinomas with heterozygous MET exon 14 skipping mutations: Implications for clinical testing

P37.21 Improvement of PCR-Based Detection of ALK Rearrangements

10PEGFR T790M mutation in treatment-naïve tumor samples: Low frequency, evidence for interaction with EGFR TKI-sensitizing mutations and lack of clear predictive value

586PSequencing of KRAS and NRAS in 1501 colorectal carcinomas reveals significant share of mutations, which are not included in common diagnostic kits

1395PLung cancers carrying distinct ALK fusion variants demonstrate similar responsiveness to ALK tyrosine kinase inhibitors

Role of CYP2D6 gene polymorphism in individual's ability to quit smoking

Hereditary Breast-Ovarian Cancer Syndrome in Russia

High frequency of BRCA1 5382insC mutation in Russian breast cancer patients

Coding polymorphisms in Casp5, Casp8 and DR4 genes may play a role in predisposition to lung cancer

First-line treatment of EGFR mutation-positive non-small cell lung cancer (NSCLC) by gefitinib

First Russian nationwide molecular epidemiological study for melanoma: results of BRAF mutation analysis

Pharmacoeconomic analysis of gefitinib therapy in patients with non-cell cell lung cancer

Suchergebnisse filtern